CanadaBis Capital Inc
CanadaBis Capital Inc scores highest on Earnings (69) and lowest on Nitro (33). Its PosiPenta is 47.61 out of 100, around the middle of similar companies.
On the Penta Grid this week, CanadaBis Capital Inc is Grid #5 of 7 in the Healthcare sector in Canada, and Grid #91 of 129 in Canada.
Compared with similar companies in the Healthcare sector in Canada.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| CanadaBis Capital Inc | 47.61 | 48 | 69 | 33 | 33 | 54 |
| Zero Candida Technologies, Inc. | 30.60 | 0 | 36 | 15 | 56 | 46 |
| Quest PharmaTech Inc. | 59.22 | 98 | 84 | 17 | 69 | 27 |
| COSCIENS Biopharma Inc. | 27.32 | 46 | 0 | 16 | 36 | 38 |
| Vaxil Bio Ltd. | 59.84 | 92 | 89 | 19 | 83 | 17 |
| Organigram Global Inc. | 57.94 | 91 | 54 | 29 | 66 | 49 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.50 |
| P/B ratio | 0.27 |
EEarnings
| Trailing EPS | ₹-0.68 |
| Forward EPS | — |
NNitro
| Price | 1.02 |
| 52-week high | 2.72 |
| 52-week low | 0.68 |
| Fall from 52-week high | 62.5% |
TTorque
| Return on equity (ROE) | -15.86% |
| Debt-to-equity | 1.05 |
AAnchor
| Beta (price swings) | 0.50 |
| Market cap | ₹14 Cr |
| Insider holding | 67.50% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is CanadaBis Capital Inc's PosiPenta score?
CanadaBis Capital Inc's PosiPenta is 47.61 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does CanadaBis Capital Inc stand on the Penta Grid?
On the Penta Grid this week, CanadaBis Capital Inc is Grid #5 of 7 in the Healthcare sector in Canada, and Grid #91 of 129 in Canada.
Which PosiPenta pillar is strongest for CanadaBis Capital Inc?
Earnings (growth), with a score of 69 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for CanadaBis Capital Inc?
Nitro (momentum), with a score of 33 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.